A cross-disciplinary University of Alberta research team has uncovered a biological marker for scleroderma that can predict which patients will develop severe disease and could also lead to new treatments.
Jan 9, 2024
0
1
Acute myeloid leukemia (AML) is a cancer type that originates in the bone marrow. Despite being considered a rare disease, it is the most common type of acute leukemia and progresses rapidly, necessitating immediate treatment.
Jan 5, 2024
0
0
The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis, according to results ...
Dec 11, 2023
0
0
Aging is associated with chronic, nonresolving inflammation, or "inflammaging," that can lead to tissue dysfunction. New findings reported in The American Journal of Pathology reveal insights into the cellular programs and ...
Dec 6, 2023
0
0
With the rapid development in computing power over the past few decades, machine-learning (ML) techniques have become popular in medical settings as a way to predict survival rates and life expectancies among patients diagnosed ...
Nov 20, 2023
0
0
Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
Nov 16, 2023
0
1
Many disorders are caused by genetic variants; to make matters worse, the genetic origin of most disorders remains unknown. Now, in a study recently published in the Journal of Clinical Immunology, researchers have shed light ...
Nov 15, 2023
0
0
Patients with sickle cell disease may soon have two new treatments to try.
Oct 30, 2023
0
1
Researchers at the National Institutes of Health have created a novel gene therapy procedure that could preserve fertility in people with sickle cell disease and other genetic blood conditions. Infertility is a high-risk ...
Oct 12, 2023
0
12
Researchers from Uppsala University have revealed one of the mechanisms behind the growth of cancer cells in the blood cancer multiple myeloma. The study shows that the protein EZH2 interacts with a specific RNA molecule ...
Sep 29, 2023
0
2
